பிதி போமா News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Investegate |Sensyne Health PLC Announcements | Sensyne Health PLC: Notice of Preliminary Results
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Investegate |Mind Gym PLC Announcements | Mind Gym PLC: Issue of ordinary shares
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Medica Group PLC (LSE:MGP) | RNS | Medica Group PLC - Issue of Equity and Total Voting Rights
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.
Grant of SAYE Options
Mind Gym (AIM: MIND), the global provider of human capital and business improvement solutions, is pleased to announce that it has launched the third year of a Save As You Earn Scheme (the SAYE Scheme ) for all eligible employees in the
UK,
0.001 pence each ( Ordinary Shares ) which have been granted at an exercise price of
144.5 pence per Ordinary Share in accordance with the terms of the SAYE Scheme. The exercise price represents a 15% discount to the average closing price of an Ordinary Share across 23, 24 and
25 June 2021, the three dealing days before the invitation was made. The Options have a contract start date of
Oxford, U.K. 19 July 2021: Sensyne Health plc (LSE: SENS) ( Sensyne or the Company ), the ethical AI company, announces an update on its strategy which now includes exploring a potential dual-listing on Nasdaq amongst other options. As stated in our financial year end trading update on 27 May 2021, the Company continues to explore strategic opportunities, including making acquisitions, that leverage its organic growth and create additional shareholder value. Any decision to list in the US would complement the Company s primary listing on the AIM market of the London Stock Exchange and Sensyne remains committed to being a UK-headquartered company. Any acquisition or strategic equity partnership would